| Lung Small Cell Carcinoma investigated in trials for …INVESTIGATED_IN_TRIALSderived15 of 133show all (up to 200) |
|---|
| → investigated in trials for | Etoposidesmall_molecule 130 trials (50 active) · roll-up of the cancer and its descendants | — | — | Lung Small Cell Carcinoma | 130 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Carboplatinsmall molecule 116 trials (42 active) · roll-up of the cancer and its descendants | — | — | Lung Small Cell Carcinoma | 116 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cisplatinsmall molecule 74 trials (20 active) · roll-up of the cancer and its descendants | — | — | Lung Small Cell Carcinoma | 74 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Topotecansmall_molecule 63 trials (23 active) · roll-up of the cancer and its descendants | — | — | Lung Small Cell Carcinoma | 63 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Atezolizumabmonoclonal_antibody 57 trials (34 active) · roll-up of the cancer and its descendants | — | — | Lung Small Cell Carcinoma | 57 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Durvalumabmonoclonal_antibody 52 trials (35 active) · roll-up of the cancer and its descendants | — | — | Lung Small Cell Carcinoma | 52 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Irinotecansmall_molecule 35 trials (7 active) · roll-up of the cancer and its descendants | — | — | Lung Small Cell Carcinoma | 35 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pembrolizumabmonoclonal antibody 35 trials (11 active) · roll-up of the cancer and its descendants | — | — | Lung Small Cell Carcinoma | 35 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Lurbinectedinsmall_molecule 29 trials (20 active) · roll-up of the cancer and its descendants | — | — | Lung Small Cell Carcinoma | 29 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Paclitaxelsmall molecule 23 trials (11 active) · roll-up of the cancer and its descendants | — | — | Lung Small Cell Carcinoma | 23 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Tarlatamabmonoclonal_antibody 22 trials (19 active) · roll-up of the cancer and its descendants | — | — | Lung Small Cell Carcinoma | 22 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Nivolumabmonoclonal antibody 21 trials (4 active) · roll-up of the cancer and its descendants | — | — | Lung Small Cell Carcinoma | 21 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Adebrelimabmonoclonal antibody 19 trials (14 active) · roll-up of the cancer and its descendants | — | — | Lung Small Cell Carcinoma | 19 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Temozolomidesmall molecule 14 trials (6 active) · roll-up of the cancer and its descendants | — | — | Lung Small Cell Carcinoma | 14 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ipilimumabmonoclonal antibody 13 trials (2 active) · roll-up of the cancer and its descendants | — | — | Lung Small Cell Carcinoma | 13 | Observed | clinicaltrials | graph → |